Viewing Study NCT02817451

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-05-23 @ 10:02 AM
Study NCT ID: NCT02817451
Status: COMPLETED
Last Update Posted: 2022-04-05
First Post: 2016-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diphtheria View
None Tetanus View
None Pertussis View
None Hepatitis B View
None Polio View
None Human Immunodeficiency Virus Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diphtheria View
None Tetanus View
None Pertussis View
None Hepatitis B View
None DTaP IPV HB PRP-T Combined Vaccine View
None Human Immunodeficiency Virus View